KaliVir Immunotherapeutics Appoints Drs. Terry Hermiston and Jon Wigginton to Board of Directors

Company Bolsters Leadership Team as it Approaches Clinical Development PITTSBURGH, June 17, 2021 -- (Healthcare Sales & Marketing Network) -- KaliVir Immunotherapeutics, Inc., a privately held biotechnology company focused on the discovery and developm... Biopharmaceuticals, Oncology, Personnel KaliVir Immunotherapeutics, vaccinia virus, immunotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news